Abstract
Our aim was to study the three-fold response to treatment, survival rates and toxicity.
Materials and methods
We review 76 patients (median age 66.2 years) affected with the disease. All received adjuvant chemotherapy, while 13 with rectal cancer were subjected to radiation too. Patients were staged after Duke’s classification.
Results
Recurrence was noted in 15 patients, 3 at stage B and 12 at stage C; median recurrence-free interval was 18.9 months. Patients without relapse had a median disease-free period of 35.9 months. Median overall survival was 35.21 months. The 5-year survival mark have surpassed 14 patients (3 with recurrent disease): 8 at stage B and 6 at stage C. Ten have died; median survival in these patients was 30.5 months. No patients suffered from severe bone marrow toxicity; mucositis and diarrhoea grade III/IV was noted in 10 patients.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Papadopoulou-Zekeridou, P., Alexandridis, E., Delithanasis, I. et al. Adjuvant chemotherapy in colorectal cancer. Tech Coloproctol 8 (Suppl 1), s149–s151 (2004). https://doi.org/10.1007/s10151-004-0140-y
Issue Date:
DOI: https://doi.org/10.1007/s10151-004-0140-y